Abstract: Corticotropin releasing factor (CRF) antagonists of formula I or II:
and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
Type:
Grant
Filed:
October 26, 2000
Date of Patent:
March 19, 2002
Assignee:
Bristol-Myers Squibb Pharma Company
Inventors:
Liqi He, Paul Gilligan, Robert Chorvat, Argyrios Georgios Arvanitis